Ermium Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Out of Business

Ermium Therapeutics General Information

Description

Developer of a biotechnology platform designed for the treatment of autoimmune inflammatory diseases. The company's platform engages in the research and development of the G protein-coupled receptor, which acts as a master regulator of inflammation via a novel mechanism of action, enabling physicians to effectively treat inflammatory diseases in patients.

Contact Information

Website
www.ermium.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 16 Boulevard Saint Germain
  • 75005 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 16 Boulevard Saint Germain
  • 75005 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ermium Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 11-Jul-2024 Completed Out of Business
3. Accelerator/Incubator 04-Aug-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 30-May-2022 $13M $13M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Ermium Therapeutics’s complete valuation and funding history, request access »

Ermium Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed for the treatment of autoimmune inflammatory diseases. The company's plat
Drug Discovery
Paris, France
9 As of 2023

Cambridge, MA

Cherry Hill, NJ
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ermium Therapeutics Competitors (5)

One of Ermium Therapeutics’s 5 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Bioincept Venture Capital-Backed Cherry Hill, NJ
Aurimi Therapeutics Venture Capital-Backed Woburn, MA
Second Genome Formerly VC-backed Brisbane, CA
Tessera Defense and Homeland Security Formerly VC-backed Dover, DE
You’re viewing 5 of 5 competitors. Get the full list »

Ermium Therapeutics Patents

Ermium Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021349324-A1 Cyclic isothiourea derivatives as cxcr4 modulators Inactive 28-Sep-2020
AU-2021349324-A9 Cyclic isothiourea derivatives as cxcr4 modulators Inactive 28-Sep-2020
CA-3190549-A1 Cyclic isothiourea derivatives as cxcr4 modulators Pending 28-Sep-2020
EP-4217353-A1 Cyclic isothiourea derivatives as cxcr4 modulators Pending 28-Sep-2020
US-20240018125-A1 Cyclic isothiourea derivatives as cxcr4 modulators Inactive 28-Sep-2020 C07D403/12
To view Ermium Therapeutics’s complete patent history, request access »

Ermium Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ermium Therapeutics FAQs

  • When was Ermium Therapeutics founded?

    Ermium Therapeutics was founded in 2019.

  • Where is Ermium Therapeutics headquartered?

    Ermium Therapeutics is headquartered in Paris, France.

  • What is the size of Ermium Therapeutics?

    Ermium Therapeutics has 9 total employees.

  • What industry is Ermium Therapeutics in?

    Ermium Therapeutics’s primary industry is Drug Discovery.

  • Is Ermium Therapeutics a private or public company?

    Ermium Therapeutics is a Private company.

  • What is Ermium Therapeutics’s current revenue?

    The current revenue for Ermium Therapeutics is .

  • How much funding has Ermium Therapeutics raised over time?

    Ermium Therapeutics has raised $13M.

  • Who are Ermium Therapeutics’s competitors?

    AnTolRx, Bioincept, Aurimi Therapeutics, Second Genome, and Tessera Defense and Homeland Security are competitors of Ermium Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process